SECTION 1 TYPICAL MUSCULOSKELETAL DEVELOPMENT

1.1 THE NEURAL CONTROL OF MOVEMENT Warwick J. Peacock (San Francisco, California, USA)

1.2 MUSCULOSKELETAL GROWTH AND DEVELOPMENT Steven E. Koop (St Paul, Minnesota, USA)

1.3 NORMAL GAIT James R. Gage and Michael H. Schwartz (St Paul, Minnnesota, USA)

SECTION 2: GAIT PATHOLOGY IN INDIVIDUALS WITH CEREBRAL PALSY

2.1 MECHANISMS AND MANIFESTATIONS OF NEONATAL BRAIN INJURY Adré DuPlessis (Boston, Massachusetts, USA)

2.2 THE PATHOPHYSIOLOGY OF SPASTICITY Warwick J. Peacock (San Francisco, California, USA)

2.3 BASAL GANGLIA INJURY AND RESULTING MOVEMENT DISORDERS Leland Albright (Madison, Wisconsin, USA)

2.4 CONSEQUENCES OF BRAIN INJURY ON MUSCULOSKELETAL DEVELOPMENT James R. Gage and Michael H. Schwartz (St Paul, Minnesota, USA)

2.5 MUSCLE STRUCTURE AND FUNCTION IN CEREBRAL PALSY Adam P. Shortland, Nicola R. Fry, Anne E. McNee and Martin Gough (London, UK)

2.6 CLASSIFICATION OF CEREBRAL PALSY AND PATTERNS OF GAIT PATHOLOGY Sylvia Ġunpuu (Hartford, Connnecticut, USA), Pam Thomason (Melbourne, Australia), Adrienne Harvey (Melbourne, Australia) and H. Kerr Graham (Melbourne, Australia)

2.7 NATURAL HISTORY OF AMBULATION WITH CEREBRAL PALSY Steven E. Koop (St Paul, Minnesota, USA)

SECTION 3: PATIENT ASSESSMENT

3.1 CLINICAL ASSESSMENT Joyce P. Trost (St Paul, Minnesota, USA)

3.2 FOOT BIOMECHANICS AND PATHOLOGY Susan Sohrweide (St Paul, Minnesota, USA)

3.3 NEUROIMAGING OF THE BRAIN Beverly Wical (St Paul, Minnesota, USA)

3.4 RAGIOGRAPHIC EVALUATION OF THE PATIENT WITH CEREBRAL PALSY KevinWalker (St Paul, Minnesota, USA)

3.5 GAIT ANALSIS: KINEMATICS, KINETICS, EMG AND OXYGEN James R. Gage and Jean Stout (St Paul, Minnesota, USA)

3.6 MODELING AND SIMULATION OF NORMAL AND PATHOLOGICAL GAIT Jennifer L. Hicks (Stanford, California, USA), Michael H. Schwartz (St Paul, Minneosta, USA) and Scott L. Delp (Stanford, California, USA)

PART 2: TREATMENT

SECTION 4: NON-OPERATIVE TREATMENT

4.1 PHYSICAL THERAPY Susan Murr and Katie Walt (St Paul, Minnesota, USA)

4.2 ORTHOSES Tom F. Novacheck, Gary J. Kroll, George Gent, Adam Rozumalski, Camilla Beattie and Michael H. Schwartz (St Paul, Minnesota, USA)

4.3 PHARMACOLOGICALTREATMENT WITH ORAL MEDICATIONS Marcie Ward (St Paul, USA)

4.4 PHARMACOLOGICAL TREATMENT WITH BOTULINUM TOXIN Kaat Desloovere and Guy Molenaers (Leuven, Belgium)

SECTION 5: OPERATIVE TREATMENT

5.1 TREATMENT OF SPASTICITY WITH INTRATHECAL BACLOFEN Linda E. Krach (St Paul, Minneosta, USA)

5.2 TREATMENT OF SPASTICITY WITH SELECTIVE DORSAL RHIZOTOMY Joyce P. Trost, Mary E. Dunn, Linda E. Krach, Tom F. Novacheck and Michael H. Schwartz (St Paul, Minnesota, USA)

5.3 NEUROSURGICAL TREATMENT OF DYSTONIA Leland Albright (Madison, Wisconsin, USA)

5.4 REHABILITATION FOLLOWING SPASTICITY REDUCTION Linda E. Krach (St Paul, Minnesota, USA)

5.5 ORTHOPAEDIC TREATMENT OF MUSCLE CONTRACTURES Tom F. Novacheck (St Paul, Minnesota, USA)

5.6 ORTHOPAEDIC TREATMENT OF LONG-BONE TORSIONS James R. Gage (St Paul, Minnesota, USA)

5.7 ORTHOPAEDIC TREATMENT OF HIP DYSPLASIA Henry G. Chambers (San Diego, California, USA)

5.8 ORTHOPAEDIC TREATMENT OF FOOT DEFORMITIES Jon R. Davids (Greenville, South Carolina, USA)

5.9 POSTOPERATIVE CARE AND REHABILITATION Steven E. Koop and Susan Murr (St Paul, Minnesota, USA)

5.10 GENERAL ISSUES OF RECURRENCE WITH GROWTH James R. Gage (St Paul, Minnesota, USA)

5.11 TREATMENT OF CROUCH GAIT Jean Stout, Tom F. Novacheck, James R. Gage and Michael H. Schwartz (St Paul, Minnesota, USA)

SECTION 6: ASSESMENT OF OUTCOME

6.1 MEASUREMENT TOOLS AND METHODS Adrienne Harvey, Pam Thomason and H. Kerr Graham (Melbourne, Australia)

6.2 CONSEQUENCES OF INTERVENTIONS Pam Thomason and H. Kerr Graham (Melbourne, Australia)